| Literature DB >> 21353386 |
Sandro Pignata1, Lucia Cannella, Davide Leopardo, Carmela Pisano, Giovanni Salvatore Bruni, Gaetano Facchini.
Abstract
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21353386 DOI： 10.1016/j.canlet.2011.01.026
Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679